Role of pICLn in Methylation of Sm Proteins by PRMT5

被引:66
|
作者
Pesiridis, G. Scott
Diamond, Evan
Van Duyne, Gregory D. [1 ]
机构
[1] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
关键词
YEAST ARGININE METHYLTRANSFERASE; COMPLEX; BINDING; CORE; IDENTIFICATION; METHYLOSOME; BIOGENESIS; EXPRESSION; INTERACTS; RESIDUES;
D O I
10.1074/jbc.M109.015578
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
pICln is an essential, highly conserved 26-kDa protein whose functions include binding to Sm proteins in the cytoplasm of human cells and mediating the ordered and regulated assembly of the cell's RNA-splicing machinery by the survival motor neurons complex. pICln also interacts with PRMT5, the enzyme responsible for generating symmetric dimethylarginine modifications on the carboxyl-terminal regions of three of the canonical Sm proteins. To better understand the role of pICln in these cellular processes, we have investigated the properties of pICln and pICln.Sm complexes and the effects that pICln has on the methyltransferase activity of PRMT5. We find that pICln is a monomer in solution, binds with high affinity (K-d similar to 160 nM) to SmD3-SmB, and forms 1: 1 complexes with Sm proteins and Sm protein subcomplexes. The data support an end-capping model of pICln binding that supports current views of how pICln prevents Sm oligomerization on illicit RNA substrates. We have found that by co-expression with pICln, recombinant PRMT5 can be produced in a soluble, active form. PRMT5 alone has promiscuous activity toward a variety of known substrates. In the presence of pICln, however, PRMT5 methylation of Sm proteins is stimulated, but methylation of histones is inhibited. We have also found that mutations in pICln that do not affect Sm protein binding can still have a profound effect on the methyltransferase activity of the PRMT5 complex. Together, the data provide insights into pICln function and represent an important starting point for biochemical analyses of PRMT5.
引用
收藏
页码:21347 / 21359
页数:13
相关论文
共 50 条
  • [41] PRMT5 is a therapeutic target in choroidal neovascularization
    Muniyandi, Anbukkarasi
    Martin, Matthew
    Sishtla, Kamakshi
    Motolani, Aishat
    Sun, Mengyao
    Jensen, Nathan R.
    Qi, Xiaoping
    Boulton, Michael E.
    Prabhu, Lakshmi
    Lu, Tao
    Corson, Timothy W.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] PRMT5 in gene regulation and hematologic malignancies
    Zhu, Fen
    Rui, Lixin
    GENES & DISEASES, 2019, 6 (03) : 247 - 257
  • [43] Arginine Methylation Mediated By PRMT5 Has Significant Biological and Clinical Impact in Multiple Myeloma
    Gulla, Annamaria
    Hideshima, Teru
    Bianchi, Giada
    Fulciniti, Mariateresa
    Samur, Mehmet K.
    Tai, Yu-Tzu
    Qi, Jun
    Harada, Takeshi
    Morelli, Eugenio
    Amodio, Nicola
    Carrasco, Ruben D.
    Tagliaferri, Pierosandro
    Munshi, Nikhil C.
    Tassone, Pierfrancesco
    Anderson, Kenneth C.
    BLOOD, 2016, 128 (22)
  • [44] Substrate adaptors are flexible tethering modules that enhance substrate methylation by the arginine methyltransferase PRMT5
    Jin, Cyrus Y.
    Hunkeler, Moritz
    Mulvaney, Kathleen M.
    Sellers, William R.
    Fischer, Eric S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (02)
  • [45] PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1
    Gao, Guozhen
    Dhar, Surbhi
    Bedford, Mark T.
    NUCLEIC ACIDS RESEARCH, 2017, 45 (08) : 4359 - 4369
  • [46] Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis
    Meng, Qi
    Lu, Yun-Xin
    Wei, Chen
    Wang, Zi-Xian
    Lin, Jin-Fei
    Liao, Kun
    Luo, Xiao-Jing
    Yu, Kai
    Han, Yi
    Li, Jia-Jun
    Tan, Yue-Tao
    Li, Hao
    Zeng, Zhao-Lei
    Li, Bo
    Xu, Rui-Hua
    Ju, Huai-Qiang
    ONCOGENE, 2022, 41 (32) : 3912 - 3924
  • [47] Antitumor Effects of PRMT5 Inhibition in Sarcomas
    Verbeke, Stephanie
    Bourdon, Aurelien
    Guegan, Jean-Philippe
    Leroy, Laura
    Chaire, Vanessa
    Richard, Elodie
    Bessede, Alban
    Italiano, Antoine
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (11): : 2211 - 2220
  • [48] Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria U.
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Arnes-Benito, Robert
    Adan-Villaescusa, Elena
    Martinez-Perez, Luz A.
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Gardini, Andrea Casadei
    Marin, Jose J. G.
    Amat, Irene
    Urman, Jesus M.
    Arechederra, Maria
    Luz Martinez-Chantar, Maria
    Trautwein, Christian
    Huch, Meritxell
    Javier Cubero, Francisco
    Berasain, Carmen
    Fernandez-Barrena, Maite G.
    Avila, Matias A.
    GUT, 2025, 74 (01) : 116 - 127
  • [49] IDENTIFICATION OF PRMT5 AS A THERAPEUTIC TARGET IN CHOLANGIOCARCINOMA
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria Ujue
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Benito, Robert Arnes
    Adan-Villaescusa, Elena
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Casadei-Gardini, Andrea
    Marin, Jose
    Amat, Irene
    Urman, Jesus
    Arechederra, Maria
    Martinez-Chantar, Maria
    Trautwein, Christian
    Huch, Meritxell
    Cubero, Francisco Javier
    Berasain, Carmen
    Fernandez-Barrena, Maite
    Avila, Matias
    HEPATOLOGY, 2024, 80
  • [50] PRMT5 Regulates DUSP4 and Plays an Important Role in Gliomagenesis
    Han, Xiaosi
    Yang, Xiuhua
    Han, Lynn K.
    Zhang, Wenbin
    Gillespie, George Y.
    Zhao, Xinyang
    Nabors, Louis B.
    ANNALS OF NEUROLOGY, 2014, 76 : S81 - S81